Royal Bank Of Canada Mirum Pharmaceuticals, Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 27,216 shares of MIRM stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,216
Previous 4,824
464.18%
Holding current value
$1.25 Million
Previous $164,000
546.95%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MIRM
# of Institutions
192Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$301 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$205 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$158 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$148 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$141 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.68B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...